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Summary Archival paraffin embedded material was used to examine whether additional quantitative criteria
would be helpful to discriminate between histologically benign and malignant rat mammary tumours. To this
end nuclear DNA content expressed as DNA ploidy index (DI) was measured using flow cytometry (FCM). A
total of 63 benign and malignant mammary tumours were investigated. Thirteen out of 38 (34%) mammary
carcinomas were DNA aneuploid against 0 out of 25 benign mammary tumours. Aneuploidy was not
significantly increased in tumours showing histological signs of greater malignancy such as cribriform-comedo
type or invasive growth. In addition to DI other quantitative criteria indicative for malignancy, such as mitotic
count and nuclear morphometric characteristics, were estimated in 24 benign and malignant tubulopapillary
tumours, a category where the histological classification may be difficult. It appeared that five out of nine
noninvasive tubulopapillary carcinomas and six out of seven invasive carcinomas had abnormal values for
either DI, mitotoic count or nuclear area or for a combination of these parameters. Each single parameter
however was abnormal only in a minority of the malignant tumours. In this respect our data are in accordance
with the fact that rat mammary carcinomas are clinically and histologically less malignant than their human
counterparts.
Breast cancer is the most common cancer to afflict women in
western countries. A number of endogenous and exogenous
factors have been identified which play a role in the patho-
genesis of breast cancer (Russo et al., 1990). The endogenous
factors include genetic and endocrine determinants while the
exogenous factors include dietary influences and ionising
radiation. The female breast is one of the tissues with a
relatively high sensitivity for radiation carcinogenesis (BEIR
Committee, 1980). Animal models are necessary for research
on the mechanisms of mammary carcinogenesis. The labora-
tory rat has been one of the most widely used species in this
regard. However, some investigators have expressed doubt as
to whether the common types of spontaneous or induced rat
mammary tumours can indeed be considered as the counter-
part of human breast cancer. The clinical behaviour of mam-
mary tumours of the rat is different from that of human
breast cancer (Williams et al., 1f981). Mammary tumours of
rats, in contrast to the situation in women are characterised
by a noninvasive or microinvasive papillary growth pattern
and a low frequency of metastasis (Van Zwieten, 1984). In
fact the distinction between benign and malignant rat mam-
mary tumours is difficult and rests on rather subjective
characteristics such as cytological atypia and a more solid
adenopapillary growth pattern in the malignant categories. In
human mammary tumours, a relationship between cellular
characteristics, such as DNA content, various morphometric
parameters, histological diagnosis and clinical behaviour has
been established (Baak et al., 1982, 1985; Cornelisse et al.,
1987; Fallenius et al., 1988; Feichter et al., 1988).
It is the purpose of the present study to determine whether
also for rat mammary tumours malignancy based on histo-
logical and cytological criteria can be associated with DNA
aneuploidy and abnormal cytomorphometric characteristics.
This would corroborate the histological criteria presently
used for distinguishing benign and malignant rat mammary
tumours and is therefore important for risk assessment
studies. The applicability of the rat as a model for human
mammary gland carcinogenesis will be endorsed when a
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similarity between human and rat cellular characteristics can
be established.
In the present study, nuclear DNA content of spontaneous
or radiation induced mammary tumours was measured by
flow cytometry (FCM) using formalin fixed tissue samples.
These data are compared with histological malignancy grade,
proliferative activity as indicated by the frequency of mitoses
and cytological characteristics such as nuclear area, perimeter
and nuclear irregularity.
Materials and methods
Animals
Paraffin blocks from rat mammary tissues used for FCM
were derived from radiation carcinogenesis studies described
by Van Zwieten (1984). Radiation induced an increased
incidence and a shortened latency period of mammary
tumours while exhibiting the same spectrum of histological
diagnoses. Estrogen treatment enhanced the effect of radia-
tion. In these studies inbred female Wag/Rij rats and
Sprague-Dawley rats in the 6th generation of inbreeding were
obtained from the specified pathogen free stock colony. After
bilateral or multilateral total body irradiation, as described
earlier (Van Zwieten, 1984), at the age of 8 weeks, they were
housed in experimental rooms under conventional conditions.
Rats of certain experimental groups were administered an
exogenous estrogenic hormone. The health of the experiment-
al animals was followed closely by bacteriological and sero-
logical monitoring. The animals were kept for their entire
lifespan, clinically examined weekly and a complete gross
necropsy was performed on those found dead or killed mori-
bund. In addition to sampling of mammary tissues a com-
plete set of other tissues and gross lesions were collected at
the same time for fixation in 10% phosphate buffered forma-
lin, paraffin embedding and preparation of histological slides.
For the present study we used representative mammary
tumour samples of the major diagnostic categories (see later).
We excluded animals which were found dead and tumour
tissue samples with necrosis exceeding 10% of the tumour
area. The great majority of the 63 mammary tumours used
for this study was derived from the treatment groups i.e. 39
animals which were irradiated and estrogen treated, 20
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animals which were irradiated only, one animal which was
treated with estrogen and three untreated rats.
Histological examination
The microscopic examination of the mammary tissues was
performed independently by two pathologists on haematoxy-
lin-phloxine-saffron (HPS) stained sections according to
the classification of Russo et al. (1990) and Van Zwieten
(1984). For our investigations representative samples of
the following diagnostic categories were selected: tubular
adenomas (n = 8), papillary cystadenomas (n = 7), fibroade-
nomas (n = 10), noninvasive (n = 9) and invasive (n = 7)
tubulopapillary carcinomas, noninvasive (n = 9) and invasive
(n = 8) cribriform-comedo carcinomas and metastasising car-
cinomas (n = 5).
Cellpreparation andstaining
Paraffin blocks of the selected benign and malignant rat
mammary tumours generally contained more than 90%
tumour cells with a few cases containing between 40 and
90% tumour cells as estimated from the corresponding HPS
stained sections. Fifty ,Lm sections were prepared from these
blocks, cleared of paraffin by two changes of xylene of
10min each and stepwise rehydrated in a series of alcohol
100%, 96%, 70% and 50% to distilled water as described by
Hedley et al. (1983). Each step took 10 min at room temper-
ature and fluids were changed twice. The rehydrated tissue
sections were washed twice with phosphate buffered saline
(PBS) and subsequently subjected to enzymatic digestion to
prepare a suspension of free nuclei. The tissue sections were
incubated for 30 min in 3 ml 0.05% protease XXIV (Sigma
P8038) a pH 7.3 at 37°C. The digestion was stopped by
adding 10 ml cold PBS. After vortexing the suspension was
filtered through a 30tm mesh nylon gauze, centrifuged,
washed with PBS, resuspended and passed twice through a
27 gauge needle. The final volume was adjusted to about 106
nucleiml-'. Ten minutes before FCM the suspension was
labelled with propidium iodide (PI) in a final concentration
of 4 sgml-'.
Flow cytometric analysis ofDNA content
Cellular DNA content was measured in at least 10,000 cells
on a modified fluorescence activated cell sorter, RELACS-3
(3-laser Rijswijk Experimental Light Activated Cell Sorter)
using an argon laser operating at 488 nm (0.5 W). Forward
light scatter and time-of-flight measurements were conducted
to eliminate aggregates and debris from the analysis. Distilled
water was used as sheath fluid. For measuring PI fluore-
scence, RG 620 and KV 550 filters (Schott Glaswerke,
Mainz, Germany) were used in front of a S-20 type photo-
multiplier (PM). The filters were used in combination with
dichroic beamsplitter FT 570 (Zeiss, Oberkochen, Germany).
Data analysis was performed by using the 8-parameter List-
mode Data Analysis Software (ELDAS), as developed in the
TNO Institute for Applied Radiobiology and Immunology
(Jonker et al., 1987).
Ploidy assessment
Ploidy assessment was performed as follows: assuming that
the first peak represented diploid cells, the DNA index (DI)
was derived by dividing the modal peak channel number of
subsequent cell populations by the modal peak channel
number of the first peak. Histograms with a coefficient of
variation (CV) greater than 8.5% in the diploid peak were
excluded from further analysis. Mean CV was 6.0 ± 1.4%.
Tumours with a distinct GO-GI population with DI> 1 were
defined as aneuploid. When more than one aneuploid peak
was present the tumour was classified as multiploid. Tetra-
ploid tumours were defined as tumours showing a G2M peak
between 1.9 and 2.1 consisting of more than 20% of the total
cells and if a peak corresponding to G2M cells of a tetra-
ploid cell population was also present.
Mitotic count
In 24 tumours we tried to relate mitotic count to DNA
aneuploidy and histological signs of malignancy. To this end
we chose material from tubulopapillary tumours in various
degrees of malignancy i.e. tubulopapillary adenomas, non-
invasive and invasive tubulopapillary carcinomas. These
tumours are comparable with respect to cell density but differ
in architecture and the presence or absence of invasion in
surrounding tissues. The number of mitoses was counted in
10 random fields at x 400 magnification in the histologically
most malignant areas and in cellular areas without any sign
of regressive or inflammatory changes of the tumours (Baak
et al., 1982, 1983).
Computer aidedmorphometry
To this end 3 gLm thick paraffin slides were prepared of the
same 24 tumours selected for establishing the mitotic count.
Morphometric analysis was performed in the most atypical
areas as judged by hypercellularity, nuclear and cellular
pleomorphism and relatively high mitotic rate. Photomicro-
graphs of these areas were made with a 63 x objective and
printed at a final magnification of 2500 x, resulting in
nuclear images of at least 20 mm diameter. At least 25
epithelial nuclei with intact nuclear outline were randomly
selected for assessment of perimeter, area, maximal diameter
and formfactor PE (4 area/quadrated perimeter). Nuclear
outlines were directly measured by using a cursor and
graphic tablet coupled with a MOP Videoplan (Kontron,
Munich, Germany; software version 5.42) microcomputer.
Statistics
Differences in frequency distribution in data groups were
assessed with the Fisher's Exact Test or Student's t-test. The
level of significance was set at P<0.05.
Results
DNA ploidy
The results are presented in Table I. None of the 25 benign
tumours were aneuploid. Of the malignant tumours 13 out of
38 (34%) were aneuploid. Aneuploidy was more frequent in
the clinically more malignant cribriform-comedo type than in
the tubulopapillary type carcinoma (9/19 vs 4/19). This
difference was however not significant. Invasiveness was not
associated with a higher incidence of aneuploidy. Multiploid
Table I DNA ploidy in 63 rat mammary tumours
Number of
animals Diploid Aneuploid
Benign
tubular adenoma 8 8 (100)' 0
papillary cystadenoma 7 7 (100) 0
fibroadenoma 10 10 (100) 0
25 (100) 0 (0)
Malignant
tubulopap. carc. 19 15 (79) 4 (21)
noninvasive 9 5 4
invasive 7 7 0
metastatic 3 3 0
cribriform-comedocarc. 19 10 (53) 9 (47)
noninvasive 9 4 5
invasive 8 6 2
metastatic 2 0 2
25 (66) 13 (34)
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or tetraploid tumours were not observed. To determine
whether previous treatment influenced the results, we com-
pared the occurrence of DNA aneuploidy for the various
diagnostic entities observed in rats treated with radiation and
estrogens with the values obtained in rats treated with radia-
tion only. Although numbers were small, no consistent
pattern associated with treatment was observed (data not
shown). The DNA ploidy distribution of all carcinomas is
represented in Figure 1. The metastatic tumours are included
within the category of invasive tumours. Within the category
of carcinomas, DNA content could not be related to the
presence or absence of invasive growth.
Mitotic count
In the series of tubulopapillary tumours, tubulopapillary car-
cinomas had a significantly higher mitotic count than the
tubular adenomas (P<0.05) (Table II). The mitotic count
varied considerably between tumours. No difference was
observed between invasive and noninvasive carcinomas.
Morphometry
The results of the nuclear measurements performed on histo-
logical slides of the eight tubulopapillary adenomas, nine
noninvasive tubulopapillary carcinomas and seven invasive
tubulopapillary carcinomas are summarised in Table III. The
mean values for area, perimeter and maximal diameter (D
max) of the nuclei were greater in both carcinoma groups as
compared to the adenoma group, reaching the level of signi-
ficance only for the invasive carcinomas as compared to the
adenoma category (P<0.05).
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Figure 1 DNA ploidy distribution of 38 rat mammary car-
cinomas; a, noninvasive (n = 18), b, invasive (n = 20). In cases
where a diploid GO-GI peak was accompanied by an aneuploid
peak, only the latter is included in this chart. The two cases with
a DI in the range 1.9-2.1 did not meet the other criteria for
tetraploidy as stated under Materials and methods.
Table II Mitotic count in tubular (papillary) tumours
Number of
animals Mitotic count'
Tubular adenoma 8 9.6±9.2a
Tubular pap. carc. noninvasive 9 25.1 ± 17.0c
Tubular pap. carc. invasive 7 28.7± 18.3c
aMean ± s.d.; bMitoses in ten random fields at x 400magnification.
cP<0.05 compared to value for tubular adenoma.
Multiparametric analysis
In order to evaluate the possibility of improving the dis-
crimination between benign and malignant tumours, we com-
pared DI, nuclear area and mitotic count in individual cases
of tubulopapillary tumours. It is especially this category
where the boundaries between benign and malignant tumours
are relatively vague and subjective, making a more quanti-
tative measure of malignancy most helpful. From the data
presented in Table IV, it appears that five out of nine non-
invasive tubulopapillary carcinomas and six out of seven
invasive carcinomas had abnormal values for one or more of
the additional parameters. In single parameter testing only
four out of 16 tubulopapillary carcinomas showed aneu-
ploidy, six out of 16 had an increased nuclear size and seven
out of 16 had an increased mitotic count. No relation could
be established between DNA aneuploidy and abnormal
mitotic count or nuclear area and between nuclear area and
mitotic count in individual cases.
Discussion
The clinical behaviour of rat mammary carcinomas is differ-
ent from that of human breast cancer i.e. they are charac-
terized by a noninvasive or microinvasive growth pattern
[about 10% invades into the surrounding tissues (Van
Zwieten, 1984)] and a low frequency ofmetastasis [about 5%
(Van Zwieten, 1984)]. Their volume doubling time is long
and may even be greater than that of benign rat mammary
tumours (Broerse et al., 1986). While this and the histological
differences between the most common human and rat mam-
mary tumours have raised doubts on the relevance of the rat
model for human carcinogenesis studies, there is a consensus
that both human and rat mammary carcinomas have a com-
parable histogenetic pathogenesis and are similarly affected
by genetic, endocrine, dietary and exogenous factors such as
carcinogens and radiation (Russo et al., 1990). The rat may
therefore serve as an animal model especially for the study of
early stages of mammary carcinogenesis and for risk assess-
ment for radiation and other carcinogenic factors. For this
an unambiguous distinction between benign and malignant
lesions is essential. As the diagnostic process based on histo-
logical and cytological appearance may be difficult (Russo et
al., 1990), we examined whether additional quantitative
criteria would be helpful to discriminate between benign and
malignant lesions.
In the present study, DNA ploidy patterns were deter-
mined in spontaneous and radiation- and or oestrogen-treat-
ment induced rat mammary tumours. DNA aneuploidy was
observed in 34% of the malignant tumours without any
relation with histological subclassification. This percentage is
low compared with the incidence of aneuploidy in mammary
carcinomas of women, dogs and cats (Feichter et al., 1988;
Barlogie et al., 1983; Rutteman et al., 1988; Hellmen et al.,
1988; Minke, 1990). It is however comparable to that obtain-
ed by Christov and Yantchev (1985) in frozen rat tumour
material using rat spleen cells as reference cells. No DNA
aneuploid cases were observed in 22 benign tumours while
only two out of eight mammary carcinomas proved to be
aneuploid.
The presence of hypoploid tumour cell populations cannot
be established with certainty on paraffin embedded material
with the present method (Hedley, 1989). Using frozen sam-526 M.J.J. GIJBELS et al.
Table III Various morphometrically established nuclear features in tubular (papillary)
tumours
Number Perimeter Area Formfactor D max
ofanimals um pm2 PE AM
Tubular adenoma 8 24.0±2.la 42.3± 7.9 0.911 ±0.022 8.0±0.6
Tubular pap. carc. 9 25.4± 1.9b 47.8± 8.3b 0.909±0.028 8.5±0.8b
noninvasive
Tubular pap. carc. invasive 7 28.2±4.2c 60.1 ± 17.7c 0.921 ±0.010 9.3± 1.4c
aMean±s.d. bOne case with extreme values excluded from calculation ofmean±s.d.
cP<0.05 compared to value for tubular adenoma.
Table IV DNA ploidy, mitotic count and nuclear area ofindividual
tubular (papillary) tumours
Mitotic
Case no. DNA index Area Wm2 counta
Tubular adenoma
I 1.00 43.2 2
2 1.00 50.1 27
3 1.00 40.0 18
4 1.00 51.2 13
5 1.00 37.3 5
6 1.00 35.4 9
7 1.00 30.2 1
8 1.00 51.0 2
Tubular papillary carcinoma: noninvasive
9 1.00 40.2 8
10 1.80* 64.6* 57*
11 1.00 40.3 2
12 1.00 39.0 18
13 1.00 50.7 30*
14 1.73* 140.0* 19
15 1.32* 49.0 21
16 1.00 49.6 28
17 1.46* 48.6 43*
Tubular papillary carcinoma: invasive
18 1.00 81.0* 29*
19 1.00 47.8 51*
20 1.00 41.4 0
21 1.00 73.4* 32*
22 1.00 63.0* 19
23 1.00 37.9 51*
24 1.00 76.3* 19
*Abnormal values; for areas and mitotic count values exceeding
mean±2 s.d. estimated in the benign tumours. aMitoses in ten random
fields at x 400 magnification.
ples, DNA hypoploid mammary carcinomas have been
demonstrated to occur in cats [(21%) Minke, 1990] and dogs
[(15%) Rutteman et al., 1988]. Whether DNA hypoploid rat
mammary tumours do occur has to await further investiga-
tions on frozen samples.
In man DNA aneuploidy is associated with a poor progno-
sis (Hiddeman et al., 1984; Dressler et al., 1988; Kallioniemi
et al., 1987). However, rats with mammary carcinomas do
not die because of generalised metastatic disease, but in the
majority are euthanised because of the large size of the
tumours or ulcerations of overlying skin. They, therefore,
might have lived for a much longer time. In man prognosis is
mostly determined as survival after time of diagnosis and
treatment. Rats are left untreated and histological diagnosis
is made after necropsy.
In human carcinomas DNA ploidy levels span the entire
range from hypoploid to hyperoctoploid (Barlogie et al.,
1983). When abnormal DI values vs survival were evaluated,
the hypoploid, multiploid and hypertetraploid patients show-
ed significantly lower survival (Coulson et al., 1984). Other
investigators observed that tumours with a higher DI (mean
1.8) had a higher malignancy grade and were more anaplastic
than tumours with a relatively low DI (mean 1.3) (McGuire
& Dressler, 1985; Moran et al., 1984; Olszewski et al., 1981).
In our study the individual DI varied from 1.3-2.0 but no
correlation between DNA content and histological malig-
nancy grade within the category of carcinomas was found
(Figure 1).
Baak et al. (1985) noticed that, in addition to histological
appearance, quantitative nuclear parameters and mitotic rate
are good predictors of prognosis in breast cancer. In our
study, we indeed found a correlation between histological
malignancy, nuclear features and mitotic count, however, no
differences were observed between invasive and noninvasive
malignant tumours.
In conclusion, our study shows that the category of histo-
logically malignant rat mammary tumours differs significantly
from benign rat mammary tumours in the relative frequency
of DNA aneuploidy, mitotic count and some quantitative
nuclear characteristics. The value of such additional techni-
ques for classifying an individual rat mammary tumour as
benign or malignant is only limited. In single parameter
testing DI was least informative with aneuploidy in about
25% of tubulopapillary carcinomas and mitotic count most
informative with abnormal values in about 50% of the cases.
Using multiparameter testing, about 70% of these carcin-
omas showed abnormal values for either DI, nuclear size or
mitotic count or for a combination of these. Our data are in
accordance with the fact that rat mammary carcinomas are
clinically and histologically less malignant than their human
counterparts.
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